Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III extension study of repeated intermittent ulipristal acetate treatment in uterine myomas
2012-001465-33Phase 3Completed
- Sponsor
- PregLem
- Start
- Jun 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ulipristal in Fibromyoma (LM), sponsored by PregLem. Primary endpoint: Myoma symptom control treatment satisfaction at visit II. Started Jun 2012; status: completed.
02
Drugs
ulipristal
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on 2012-001465-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001465-33.